Omeprazole and atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation in patients undergoing percutaneous coronary intervention in a tertiary health care system: A prospective drug –drug interaction study

Conclusion A prominent drug–drug interaction was observed with patients on dual antiplatelet therapy along with omeprazole and atorvastatin.

Source: IJC Metabolic and Endocrine - October 28, 2016 Category: Endocrinology Source Type: research